Niche-mediated depletion of the normal hematopoietic stem cell reservoir by Flt3-ITD–induced myeloproliferation
Authors:
- Adam J. MeadAMAdam J. Mead
- Wen Hao NeoWNWen Hao Neo
- Nikolaos BarkasNBNikolaos Barkas
- Alice GiustacchiniAlice Giustacchini
- Raffaella FacchiniRFRaffaella Facchini
- Supat ThongjueaSTSupat Thongjuea
- Christopher A.G. BoothCBChristopher A.G. Booth
- Nicholas FordhamNFNicholas Fordham
- Cristina Di GenuaCGCristina Di Genua
Open Access
- 21 June 2017
- journal article
- research article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 214 (7) , 2005-2021
Abstract
Although previous studies suggested that the expression of FMS-like tyrosine kinase 3 (Flt3) initiates downstream of mouse hematopoietic stem cells (HSCs), FLT3 internal tandem duplications (FLT3 ITDs) have recently been suggested to intrinsically suppress HSCs. Herein, single-cell interrogation found Flt3 mRNA expression to be absent in the large majority of phenotypic HSCs, with a strong negative correlation between Flt3 and HSC-associated gene expression. Flt3-ITD knock-in mice showed reduced numbers of phenotypic HSCs, with an even more severe loss of long-term repopulating HSCs, likely reflecting the presence of non-HSCs within the phenotypic HSC compartment. Competitive transplantation experiments established that Flt3-ITD compromises HSCs through an extrinsically mediated mechanism of disrupting HSC-supporting bone marrow stromal cells, with reduced numbers of endothelial and mesenchymal stromal cells showing increased inflammation-associated gene expression. Tumor necrosis factor (TNF), a cell-extrinsic potent negative regulator of HSCs, was overexpressed in bone marrow niche cells from FLT3-ITD mice, and anti-TNF treatment partially rescued the HSC phenotype. These findings, which establish that Flt3-ITD–driven myeloproliferation results in cell-extrinsic suppression of the normal HSC reservoir, are of relevance for several aspects of acute myeloid leukemia biology.Keywords
Funding Information
- Bloodwise
- Medical Research Council (MR/L006340/1)
- MRC (G0801073, MC_UU_12009/5)
- Swedish Research Council
- Bloodwise
- Wellcome Trust
- MRC
- Oxford Consortium for Single-Cell Biology (MR/M00919X/1)
- WIMM Flow Cytometry Facility
- MRC
- Human Immunology Unit
- MRC
- Molecular Haematology Unit (MC_UU_12009)
- National Institute for Health Research
- Oxford Biomedical Research Centre
- John Fell Fund (131/030, 101/517)
- E.P. Abraham Research Fund (CF182, CF170)
- WIMM Strategic Alliance (G0902418, MC_UU_12025)
This publication has 58 references indexed in Scilit:
- FLT3-ITDs Instruct a Myeloid Differentiation and Transformation Bias in Lymphomyeloid Multipotent ProgenitorsCell Reports, 2013
- Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemiaNature, 2012
- The earliest thymic T cell progenitors sustain B cell and myeloid lineage potentialNature Immunology, 2012
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencingNature, 2012
- Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune responseNature Reviews Immunology, 2011
- Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptorsJournal of Experimental Medicine, 2011
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- FLT3 Mutations Confer Enhanced Proliferation and Survival Properties to Multipotent Progenitors in a Murine Model of Chronic Myelomonocytic LeukemiaCancer Cell, 2007
- Identification of a new intrinsically timed developmental checkpoint that reprograms key hematopoietic stem cell propertiesProceedings of the National Academy of Sciences, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005